Error in Figure/Table
In the published article, there was an error in Table 2 “Analysis of the associations between AE-device therapy and outcomes.” as published. We did not update the latest table in the final correction process, which resulted in its inconsistency with the text in the two sections of the abstract and results. The latest data should be “Adjusted: ICU mortality: HR = 0.48, 95% CI = 0.24–0.96, P = 0.039; Day 28 mortality: HR = 0.50, 95% CI = 0.27–0.90, P = 0.021”, not “Adjusted: ICU mortality: HR = 0.46, 95% CI = 0.23–0.93, P = 0.030; Day 28 mortality: HR = 0.49, 95% CI = 0.27–0.89, P = 0.020” as in the uncorrected table. The corrected Table 2 appears below.
Table 2
| Non-AE device therapy | AE-device therapy | P-value | |
|---|---|---|---|
| HR (95%CI) | HR (95%CI) | ||
| ICU Mortality | |||
| Unadjusted | Reference | 0.32 (0.22,0.48) | <0.001 |
| Adjusted | Reference | 0.48 (0.24,0.96) | 0.039 |
| Day 28 Mortality | |||
| Unadjusted | Reference | 0.44 (0.31,0.62) | <0.001 |
| Adjusted | Reference | 0.50 (0.27,0.90) | 0.021 |
Analysis of the associations between AE-device therapy and outcomes. Analysis of the associations between AE-device therapy and outcomes.
Analysis of the associations between AE-device therapy and outcomes. HR, hazard ratio; CI, confidence interval.
Models were derived from Cox proportional hazards regression models.
Model I was not adjusted for covariates.
Model II covariates were adjusted for Age, Weight, Ethnicity, Gender, First_careunit, APSIII, Anion_Gap, Heart_rate_mean, CKMB, WBC, Respiratory_rate_mean, Mbp_mean, SpO2_mean, Temperature_mean, Troponin_T_Max, Hemoglobin, Glucose_max, INR, Platelet, Potassium, Creatinine, Urea_Nitrogen, ALT, Urine_output, Lactate, Anti_Embolic, Antiplatelet, Anticoagulation, Congestive_heart_failue, Renal_disease, Malignant_cancer, Liver_disease, PCI, CABG, Ventilator, Vasopressor, CRRT, Peripheral_vascular_disease, Cerebrovascular_disease, Chronic_pulmonary_disease, Hypertensionid
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Text Correction
In the published article, there was an error. In the Abstract, the HR, 95% CI, and P-values corresponding to 28-day mortality are incorrectly written as those corresponding to ICU mortality and the HR, 95% CI, and P-values for ICU mortality are written as those corresponding to 28-day mortality and here should use HR instead of OR. A correction has been made to Abstract-“Results”, Line 3–6 of the first paragraph. This sentence previously stated:
“In the multivariate analysis, compared with no-AE device therapy, AE device therapy was a significant predictor of 28-day mortality (OR = 0.48, 95% CI = 0.24–0.96, P = 0.039) and ICU mortality (OR = 0.50, 95% CI = 0.27–0.90, P = 0.021).”
The corrected sentence appears below:
“In the multivariate analysis, compared with no-AE device therapy, AE device therapy was a significant predictor of ICU mortality (HR = 0.48, 95% CI = 0.24–0.96, P = 0.039) and 28-day mortality (HR = 0.50, 95% CI = 0.27–0.90, P = 0.021).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Text Correction
In the published article, there was an error. In the Results sections of this paper, the HR, 95% CI, and P-values corresponding to 28-day mortality are incorrectly written as those corresponding to ICU mortality and the HR, 95% CI, and P-values for ICU mortality are written as those corresponding to 28-day mortality, and here should use HR instead of OR. A correction has been made to Section of Results-“Cox Proportional-hazards Models”, Line 3–6 of the first paragraph. This sentence previously stated:
“As listed in Table 2, compared with no-AE device therapy, AE device therapy was a significant predictor of 28-day mortality (OR = 0.48, 95% CI = 0.24–0.96, P = 0.039) and ICU mortality (OR = 0.50, 95% CI = 0.27–0.90, P = 0.021) after adjusting for covariates.”
The corrected sentence appears below:
“As listed in Table 2, compared with no-AE device therapy, AE device therapy was a significant predictor of ICU mortality (HR = 0.48, 95% CI = 0.24–0.96, P = 0.039) and 28-day mortality(HR = 0.50, 95% CI = 0.27–0.90, P = 0.021) after adjusting for covariates.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
anti-embolic therapy, acute myocardial infarction, type II diabetes mellitus, mortality, ICU
Citation
Huang X, Zhang L, Xu M, Yuan S, Ye Y, Huang T, Yin H and Lyu J (2023) Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus. Front. Cardiovasc. Med. 10:1143652. doi: 10.3389/fcvm.2023.1143652
Received
13 January 2023
Accepted
16 February 2023
Published
09 March 2023
Approved by
Xiaofeng Yang, Temple University, United States
Volume
10 - 2023
Updates
Copyright
© 2023 Huang, Zhang, Xu, Yuan, Ye, Huang, Yin and Lyu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Haiyan Yin Yinhaiyan1867@126.com Jun Lyu lyujun2020@jnu.edu.cn
These authors have contributed equally to this work
Specialty Section: This article was submitted to Cardiovascular Pharmacology and Drug Discovery, a section of the journal Frontiers in Cardiovascular Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.